Investor profile

Calculus Capital logo

Calculus Capital

GBHealthtechBio/PharmaB2B SaaSAI/MLFintechEnterpriseConsumerOther

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

Calculus Capital is a pioneer in the UK tax-efficient investment space, having launched the UK's first approved EIS fund in 1999. The firm specialises in creating and managing EIS and VCT funds that build diversified portfolios of innovative, entrepreneurial UK growth companies — with a particular focus on technology, life sciences, and entertainment/media. Calculus targets smaller, unquoted UK businesses with strong management teams and high growth potential, providing development and scale-up capital typically in the £1m–£7m range per round. The firm takes an active, partnership-oriented approach, frequently taking board seats and supporting portfolio companies through multiple funding rounds to profitable exit.

Notable quotes

It was a relatively inexpensive sector for investors to get into; there was strong consumer demand for quality content.

John Glencross · Screen Daily interview, November 2024 · 2024-11

We were attracted to the company not only for its novel science, but its exceptional management team.

Elizabeth Klein · Calculus Capital press release – Tagomics investment, February 2024 · 2024-02

It's been a real pleasure working with Chris McCullough and the Rotageek team over the past five years.

Alexander Crawford · Alexander Crawford LinkedIn post – Rotageek exit, November 2025 · 2025-11

Team

John Glencross

CEO & Co-Founder

B2B SaaSHealthtechConsumerEnterprise

Alexander Crawford

Co-Head of Investments

B2B SaaSAI/MLEnterpriseFintech

Richard Moore

Co-Head of Investments

B2B SaaSEnterpriseFintech

Elizabeth Klein

Investment Director

HealthtechBio/Pharma

Dominic Harris

Head of Portfolio Management

HealthtechBio/PharmaEnterprise

Robert Davis

Investment Director

B2B SaaSEnterprise

Recent investments

CompanyRoundSizeDate
Resurrect BioSeries A2026-02-17
TrogenixSeries A$88m2025-10
Grateful (Grtfl)Seed$2m2025-10
Laverock TherapeuticsSeed$28m2025-06
EnsiliTechSeed$6m2025-08
TagomicsSeries A$9m2024-02-21
OptalitixSeries A$3m2024-09-11
InviziusSeries A2024-09-23
eConsult HealthSeries A$9m
Wonderhood StudiosGrowth

Frequent co-investors

Fit check

Is Calculus Capital a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit